首页> 外文会议>American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics >Determination of Dexamethasone To 13 pg/g (mL) in Ocular Fluids and Tissues Following Unilateral, Topical Administration
【24h】

Determination of Dexamethasone To 13 pg/g (mL) in Ocular Fluids and Tissues Following Unilateral, Topical Administration

机译:在单侧局部给药后的眼液和组织中测定地塞米松至13 pg / g(ml)

获取原文

摘要

The application of pharmacokinetics to the study of the efficacy of ocular drugs, the PK/PD relationship, is integral to drug discovery/development. Quantitative analysis of drug in ocular tissues if often challenging. This paper describes a method for determination of the concentration of dexamethasone (DEX) in ocular tissues with a LLOQ of 13 pg/g. Plasma, aqueous humor, vitreous humor, retina, and choroid were analyzed. Instrumentation was HTC PAL, Fisher Scientific Accela Pump and Thermo Fisher Scientific TSQ Quantum Ultra. Reversed phase LC (C-18); gradient conditions; APCI; Thermo TSQ Ultra; Resolution, 0.7 daltons at half peak height; centroid; SRM, DEX. ([~(2)H_(4)]-DEX): m/z velence 393 (397) CAD to 373 (377), loss of HF (-10 volts) (-HF). The +APCI method was observed to be rugged and reproducible and met CDER guidelines. Back calculated concentrations for 13, 27, 53 and 106 pg/mL were -12, 2.6, -9.6 and -1.6percent, respectively. A LLOQ of 13 pg/mL (g) was observed using these conditions. The concentration of DEX in anterior retina samples varied from 0.6 to 2.4 ng/g and 0.9 to 14 ng/mL in the untreated and treated eyes, respectively. The concentration of DEX in posterior retina samples varied from < LLOQ to 1.7 ng/g and < LLOQ to 4.8 ng/mL in the untreated and treated eyes, respectively. The concentration of DEX in anterior choroid samples varied from 1.1 to 6.2 ng/g and 5.0 to 46 ng/mL in the untreated and treated eyes, respectively. The concentration of DEX in posterior choroid samples varied from < LLOQ to 5.2 ng/g and < LLOQ to 4.7 ng/mL in the untreated and treated eyes, respectively. A method is described with an approximate one order of magnitude lower LLOQ for DEX relative to literature methods. This method has been applied to the determination of the pharmacokinetics of DEX in ocular tissues of rabbits and in tissues excised bi-laterally following unilateral topical administration.
机译:药代动力学在研究眼药药物,PK / Pd关系的研究中的应用是不可或缺的药物发现/发育。经常具有挑战性,在眼组织中的定量分析。本文描述了一种测定眼部组织中的地塞米松(DEX)浓度的方法,LLOQ为13 pg / g。分析了血浆,幽默,玻璃湿气,视网膜和脉络膜。仪器是HTC PAL,Fisher Scientific Accela泵和Thermo Fisher Scientific TSQ量子Ultra。反转阶段LC(C-18);梯度条件; APCI; Thermo Tsq Ultra;分辨率,半峰高的0.7道尔顿;质心; SRM,DEX。 ([〜(2)H_(4)] - dex):M / z柔性393(397)CAD至373(377),HF(-10伏)丧失(-HF)。观察到+ APCI方法是坚固耐用的和可再现的,并达到CDED指南。返回计算浓度为13,27,53和106pg / ml分别为-12,2.6,-9.6和-1.6%。使用这些条件观察13pg / ml(g)的LLOQ。在未处理和处理的眼睛中,前视网膜样品中DEX浓度从0.6至2.4ng / g和0.9至14ng / ml变化。后视网膜样品中的DEX的浓度分别在未处理和处理的眼睛中从

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号